Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial


Schermata 2014-02-19 alle 22.13.45

Prana Investor Presentation and Audio Recording

FEBRUARY 2014: MELBOURNE, Australia and NEW YORK, USA: Prana Biotechnology (ASX:PBT / NASDAQ:PRAN) this morning delviered a presentation for investors regarding the results of its Phase 2 clinical trial of PBT2 in patients with Huntington’s disease.

The full presentation, including audio, can be viewed here.

The slide deck can be viewed here.


Source: Prana Biotechnology Limited

Print Friendly, PDF & Email